Search

Your search keyword '"Perez-Mancera, Pedro A."' showing total 133 results

Search Constraints

Start Over You searched for: Author "Perez-Mancera, Pedro A." Remove constraint Author: "Perez-Mancera, Pedro A."
133 results on '"Perez-Mancera, Pedro A."'

Search Results

2. KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice

3. Mouse Models of Pancreatic Exocrine Cancer

4. Figure S7 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer

5. Supplementary Table S12 from Tissue-Specific Oncogenic Activity of KRASA146T

6. Supplementary Tables S14-S17 from Tissue-Specific Oncogenic Activity of KRASA146T

7. Data from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer

8. Data from Tissue-Specific Oncogenic Activity of KRASA146T

9. Supplementary Figures S1-S18 from Tissue-Specific Oncogenic Activity of KRASA146T

10. Supplementary Table 3 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

11. Supplementary Table 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

12. Supplementary Table 4 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

13. Data from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

14. Supplemental Methods from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

15. Supplementary Figure Legends, Supplementary Tables 1 and 2 and Supplementary Materials and Methods from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

16. Supplementary Figures 1 through 9 from Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

17. Data from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

18. Supplementary Table 2 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

19. Supplementary Figure 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

20. Supplementary Figure 2 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

22. Abstract C084: Oncogenic KRAS signaling drives the activation of tissue-resident fibroblasts and is required to maintain CAF heterogeneity in pancreatic cancer

25. Abstract 3647: Oncogenic Kras drives cancer-associated fibroblast heterogeneity and substate changes in pancreatic cancer

27. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma

30. A novel scaffold based hybrid multicellular model for pancreatic ductal adenocarcinoma – towards a better mimicry of the in vivo tumour microenvironment

31. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry

32. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

34. ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium

35. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

36. Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

38. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer

39. PDAC-associated fibroblasts are less responsive to an anti-fibrotic stimulus and more responsive to a positive regulator of fibroblast activation than normal activated fibroblasts

40. Tissue-Specific Oncogenic Activity of KRASA146T

41. Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

42. Disease associated fibroblasts from various pancreatic disorders exhibit subtype specific genetic profile

45. Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

46. Identification of novel signalling pathways dysregulated in pancreatic cancer-associated fibroblasts

47. Abstract 798: Clonal analysis and clinical translation of pancreatic adenocarcinoma genomes.

50. Erratum: Corrigendum: Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Catalog

Books, media, physical & digital resources